MTEX MTEX
Company Profile ↓Company Overview
MTEX (MTEX) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Recent Developments
- Dec 2025 Revenue of $108.04M (-8.3% YoY); net profit $-15.21M.
- Trailing 12 Months Year-on-year growth — revenue -8.3%, earnings -711.0%.
- 5-Year Trend Long-term compounding — revenue CAGR -7.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -7.18% |
| 1 Year: | -8.34% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | -710.96% |
Stock Price Performance
| 1 Year: | -39.93% |
| 6 Months: | -33.73% |
| 3 Months: | +6.74% |
| 1 Month: | +0.60% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)53.86 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Revenue declined at -7.2% CAGR over 5 years.
- Trading 50.2% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2013 | Jun 2013 | Sep 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 41.38M | 45.14M | 43.01M | 37.97M | 40.71M | 39.66M | 36.60M | 37.65M | 37.97M | 38.32M | 42.50M | 39.45M | 32.38M | 34.98M | 35.51M | 34.11M | 32.59M | 32.55M | 29.39M | 27.74M | 31.73M | 26.56M | - | 29.16M | 24.92M |
| Gross Profit | 33.97M | 36.11M | 35.21M | 33.56M | 36.56M | 45.33M | 35.82M | 38.46M | 35.61M | 32.32M | 38.71M | 38.41M | 31.88M | 38.90M | 33.76M | 33.13M | 37.00M | 33.98M | 30.55M | 32.60M | 31.95M | 29.60M | 28.94M | 28.64M | 31.10M | 32.38M | 31.54M | 25.29M | 27.06M | 28.10M | 26.70M | 25.59M | 25.93M | 23.10M | 21.38M | 23.62M | 19.74M | - | 22.27M | 18.86M |
| Operating Income | 655.00K | 1.55M | 429.00K | 1.38M | 600.00K | 8.20M | 2.51M | 4.61M | 2.23M | 536.00K | -112.00K | 507.00K | -2.03M | 2.82M | 684.00K | -888.00K | -349.00K | 1.67M | 1.12M | 2.02M | 565.00K | 2.01M | 1.11M | 1.38M | 2.79M | 2.02M | 3.29M | 35.00K | 853.00K | 1.36M | 713.00K | -954.00K | 172.00K | 820.00K | -1.14M | 887.00K | -833.00K | - | 2.01M | -180.00K |
| Net Income | 644.00K | 784.00K | -801.00K | 228.00K | -692.00K | 5.11M | 1.10M | 3.14M | 68.00K | 591.00K | -1.33M | 1.28M | -1.25M | 1.79M | 1.38M | -264.00K | -384.00K | -1.66M | 688.00K | 1.99M | -1.49M | 2.79M | 1.13M | 1.62M | 2.19M | 2.13M | 134.00K | 134.00K | 694.00K | 604.00K | 604.00K | -1.10M | 18.00K | 1.18M | -624.00K | -328.00K | -1.53M | -4.31M | 1.92M | 950.00K |
| Diluted EPS | 0.24 | 0.30 | -0.30 | 0.08 | -0.26 | 1.89 | 0.40 | 1.15 | 0.03 | 0.21 | -0.49 | 0.46 | -0.46 | 0.65 | 0.50 | -0.10 | -0.14 | -0.69 | 0.28 | 0.81 | -0.62 | 1.15 | 0.47 | 0.76 | 1.04 | 0.99 | 1.44 | 0.06 | 0.34 | 0.61 | 0.32 | -0.59 | 0.01 | 0.63 | -0.33 | -0.17 | -0.80 | - | 1.01 | 0.49 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 412.68M | 332.70M | 289.70M | 228.09M | 200.70M | 173.40M | 177.40M | 190.10M | 180.30M | 180.30M | 176.70M | 173.56M | 157.73M | 151.41M | 159.76M | 137.21M | 131.96M | 117.87M | 108.04M |
| Gross Profit | 163.85M | 134.54M | 96.48M | 98.02M | 162.17M | 138.81M | 141.33M | 151.73M | 146.16M | 143.74M | 141.03M | 139.08M | 126.18M | 115.90M | 125.61M | 104.15M | 102.86M | 91.46M | 80.96M |
| Operating Income | 7.61M | -14.50M | -25.59M | -11.48M | -16.89M | -980.00K | 4.76M | 12.74M | 12.14M | 661.00K | 2.52M | -90.00K | 6.43M | 4.49M | 9.05M | -405.00K | -964.00K | 1.43M | -426.00K |
| Net Income | 6.59M | -12.63M | -17.37M | -10.62M | -20.66M | -1.39M | 3.17M | 6.50M | 5.84M | -586.00K | -1.79M | -3.89M | 3.29M | 6.26M | 9.84M | -4.49M | -2.24M | 2.49M | -15.21M |
| Diluted EPS | 0.25 | -0.48 | -6.56 | -4.01 | -7.80 | -0.52 | 1.18 | 2.40 | 2.14 | -0.22 | -0.66 | -1.53 | 1.35 | 2.77 | 4.71 | -2.35 | -1.20 | 1.32 | -8.00 |
| R&D Expense | - | - | - | - | 3.00M | 1.90M | 1.60M | 1.60M | 1.70M | 1.40M | 1.20M | 1.00M | 1.10M | 800.00K | 1.20M | 1.00M | 800.00K | 700.00K | 800.00K |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 124.06M | 102.30M | 81.42M | 58.27M | 48.12M | 56.06M | 67.40M | 68.64M | 71.19M | 76.24M | 62.20M | 62.92M | 65.33M | 59.62M | 49.13M | 41.21M | 36.06M | 29.99M |
| Total Equity | 88.80M | 86.86M | 68.73M | 51.28M | 41.08M | 21.65M | 20.22M | 23.45M | 31.38M | 38.56M | 38.88M | 40.24M | 25.32M | 27.27M | 25.97M | 24.41M | 14.18M | 10.48M | 8.61M | -5.22M |
| Cash & Equivalents | 45.70M | 47.10M | 30.95M | 17.37M | 21.58M | 18.06M | 14.38M | 20.39M | 28.00M | 31.99M | 28.69M | 37.68M | 21.84M | 24.76M | 22.21M | 24.18M | 13.78M | 7.73M | 11.40M | 6.18M |
| Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.75M |
| Total Liabilities | - | - | 55.33M | 51.02M | 40.34M | 36.62M | 27.90M | 32.61M | 36.02M | 30.08M | 32.30M | 36.00M | 36.87M | 35.65M | 39.36M | 35.21M | 34.95M | 30.72M | 27.44M | 35.22M |
| Current Liabilities | - | - | 45.52M | 42.68M | 32.24M | 29.88M | 24.78M | 30.06M | 33.01M | 26.38M | 29.98M | 33.45M | 33.61M | 28.89M | 31.99M | 30.10M | 29.84M | 25.78M | 20.90M | 18.73M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | -2.87M | -1.53M | 8.56M | - | - | - | - | -222.00K | 4.92M | 6.03M | 10.77M | -2.60M | -2.37M | 2.26M | -2.96M |
| Investing Cash Flow | - | - | - | - | -623.00K | -268.00K | -601.00K | - | - | - | - | -2.28M | -1.22M | -947.00K | -650.00K | -1.06M | -747.00K | -285.00K | -1.35M |
| Financing Cash Flow | - | - | - | - | -1.17M | -1.08M | -1.55M | - | - | - | - | -12.05M | -2.71M | -9.92M | -9.29M | -4.33M | -1.90M | 1.96M | -561.00K |
| Capital Expenditure | -13.41M | -5.61M | -2.80M | -1.77M | -777.00K | -379.00K | -602.00K | -1.53M | -1.98M | -2.29M | -1.34M | -2.34M | -1.22M | -949.00K | -650.00K | -1.06M | -748.00K | -297.00K | -1.35M |
| Free Cash Flow | - | - | - | - | -3.65M | -1.91M | 7.96M | - | - | - | - | -2.56M | 3.70M | 5.08M | 10.12M | -3.66M | -3.12M | 1.96M | -4.32M |
| Share Buybacks | - | - | 0 | 0 | 0 | 3.00K | 0 | - | 0 | 274.00K | 226.00K | 7.54M | 294.00K | 5.93M | 5.05M | 1.98M | 176.00K | 0 | - |
| Dividends Paid | 9.52M | 5.82M | 1.06M | 0 | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 39.7% | 40.4% | 33.3% | 43.0% | 80.8% | 80.0% | 79.7% | 79.8% | 81.1% | 79.7% | 79.8% | 80.1% | 80.0% | 76.5% | 78.6% | 75.9% | 78.0% | 77.6% | 74.9% |
| Operating Margin % | 1.8% | -4.4% | -8.8% | -5.0% | -8.4% | -0.6% | 2.7% | 6.7% | 6.7% | 0.4% | 1.4% | -0.1% | 4.1% | 3.0% | 5.7% | -0.3% | -0.7% | 1.2% | -0.4% |
| Net Margin % | 1.6% | -3.8% | -6.0% | -4.7% | -10.3% | -0.8% | 1.8% | 3.4% | 3.2% | -0.3% | -1.0% | -2.2% | 2.1% | 4.1% | 6.2% | -3.3% | -1.7% | 2.1% | -14.1% |
| ROE % | 7.6% | -18.4% | -33.9% | -25.8% | -95.4% | -6.9% | 13.5% | 20.7% | 15.1% | -1.5% | -4.4% | -15.3% | 12.1% | 24.1% | 40.3% | -31.7% | -21.4% | 28.9% | 291.3% |
| ROCE % | - | -18.5% | -42.9% | -23.3% | -59.5% | -4.2% | 18.3% | 37.1% | 28.7% | 1.6% | 5.9% | -0.3% | 18.9% | 13.5% | 30.6% | -2.1% | -6.2% | 9.4% | -3.8% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for MTEX
Mannatech Announces Appointment of Yasir Haider as Chief Financial Officer
FLOWER MOUND, Texas, June 08, 2026 (GLOBE NEWSWIRE) -- Mannatech, Incorporated (NASDAQ: MTEX) announces that on June 3, 2026, Yasir Haider was appointed Chief Financial Officer of Mannatech, Incorporated (the "Company"). Mr. Haider joined t…
Mannatech Announces Results of Annual Shareholders’ Meeting
FLOWER MOUND, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- Mannatech, Incorporated (Nasdaq: MTEX) (the "Company"), a global health and wellness company committed to transforming lives to make a better world, announced that its shareholders pass…
Mannatech Reports Financial Results for First Quarter 2026
FLOWER MOUND, Texas, May 14, 2026 (GLOBE NEWSWIRE) -- Mannatech, Incorporated (NASDAQ: MTEX), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial r…
Mannatech Reports Financial Results for Fourth Quarter and Year Ended 2025
FLOWER MOUND, Texas, April 17, 2026 (GLOBE NEWSWIRE) -- Mannatech, Incorporated (NASDAQ: MTEX), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial…
Mannatech Announces Notification of Late Filing
FLOWER MOUND, Texas, April 01, 2026 (GLOBE NEWSWIRE) -- Mannatech, Incorporated (NASDAQ: MTEX), (“Mannatech” or “the Company”) announced today that it has filed a Form 12b-25, Notification of Late Filing, with the U.S. Securities and Exchan…
Mannatech Reports Financial Results for Third Quarter 2025
FLOWER MOUND, Texas, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Mannatech, Incorporated (NASDAQ: MTEX), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial …
MTEX — Frequently Asked Questions
What is the current share price of MTEX?
As of 2026-08-05 17:25 PDT, MTEX trades at $5.07 on NASDAQ/NYSE. Its 52-week range is $3.95 to $10.19.
What is the P/E ratio of MTEX?
MTEX trades at a trailing price-to-earnings (P/E) ratio of -0.63.
Is MTEX a good stock to buy?
This page provides a data-driven analysis of MTEX, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.